MDM2 Antagonist RO5045337

An MDM2 (human homolog of double minutes-2; HDM2) antagonist with potential antineoplastic activity. RO5045337 binds to MDM2, thereby preventing the binding of the MDM2 protein to the transcriptional activation domain of the tumor suppressor protein p53. By preventing this MDM2-p53 interaction, the proteosome-mediated enzymatic degradation of p53 is inhibited and the transcriptional activity of p53 is restored, which may result in the restoration of p53 signaling and thus the p53-mediated induction of tumor cell apoptosis. MDM2, a zinc finger protein, is a negative regulator of the p53 pathway; often overexpressed in cancer cells, it has been implicated in cancer cell proliferation and survival. (NCI Thesaurus)

YOU MAY ALSO LIKE

MDL 101,731

A drug that belongs to a family of drugs called ribonucleotide reductase inhibitors.

MDK wt Allele

Human MDK wild-type allele is located in the vicinity of 11p11.2 and is approximately 2 kb in length. This allele, which encodes…

MDK Gene

This gene is involved in nervous tissue development. It plays a role in neuronal differentiation, growth, regeneration and survival.

MDC1 wt Allele

Human MDC1 wild-type allele is located in the vicinity of 6p21.3 and is approximately 18 kb in length. This allele, which encodes…

MDC1 Gene

This gene plays a role in cell cycle progression.

MD Anderson Symptom Inventory - Lung Chemoradiation

A self-administered questionnaire designed specifically for evaluating the severity of symptoms related to lung cancer and chemoradiation treatment.